Invention Grant
- Patent Title: Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
-
Application No.: US15668817Application Date: 2017-08-04
-
Publication No.: US10300072B2Publication Date: 2019-05-28
- Inventor: Jose Aiguade Bosch , Silvia Gual Roig , Maria Prat Quinones , Carlos Puig Duran
- Applicant: ALMIRALL, S.A.
- Applicant Address: ES Barcelona
- Assignee: Almirall, S.A.
- Current Assignee: Almirall, S.A.
- Current Assignee Address: ES Barcelona
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: EP11382344 20111111
- Main IPC: C07D403/12
- IPC: C07D403/12 ; A61K31/538 ; C07D413/14 ; C07D409/12 ; C07D409/14 ; C07D417/14 ; A61K31/4178 ; A61K31/423 ; A61K31/428 ; A61K31/4709 ; A61K45/06 ; C07D263/58 ; C07D401/12 ; C07D413/12 ; C07D417/12 ; A61K31/4184
Abstract:
The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
Public/Granted literature
- US20180015097A1 CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES Public/Granted day:2018-01-18
Information query
